#15544 (no title)
#15471 (no title)
#15359 (no title)
¿Cómo?
¿Cuáles son los objetivos del JPND?
2011 Report
2012
2012 Research Strategy
2013
2016 Report
2017 Stakeholder Consultation
2019 Research and Innovation Strategy
2019 Research Call on “Personalised Medicine”
- Country-Specific Details
- Personalised Medicine Projects
2020 Research Call on “Novel Imaging and Brain Stimulation Methods and Technologies Related to Neurodegenerative Diseases”
- Country-Specific Details
- Novel Imaging and Brain Stimulation Methods and Technologies Projects
2021 Expert Working Groups Call On “THE IMPACT OF COVID-19 ON NEURODEGENERATIVE DISEASE RESEARCH”
2021 Research Call on “LINKING PRE-DIAGNOSIS DISTURBANCES OF PHYSIOLOGICAL SYSTEMS TO NEURODEGENERATIVE DISEASES”
- Country-Specific Details
- Linking Pre-Diagnosis Disturbances of Physiological Systems to Neurodegenerative Diseases Projects
2022 EXPERT WORKING GROUPS CALL ON “CONCEPTS FOR HEALTH AND SOCIAL CARE RESEARCH FOR NEURODEGENERATIVE DISEASES”
2022 Research Call on “UNDERSTANDING THE MECHANISMS OF NON-PHARMACOLOGICAL INTERVENTIONS”
- Country-Specific Details
- Understanding the Mechanisms for Non-Pharmacological Interventions Projects
2023 RESEARCH CALL ON “LARGE SCALE ANALYSIS OF OMICS DATA FOR DRUG-TARGET FINDING IN NEURODEGENERATIVE DISEASES”
- Country-Specific Details
- Large Scale Analysis of OMICS Data for Drug-Target Finding in Neurodegenerative Diseases Projects
2023 Working Groups Call on “Use of Digital Technologies in Neurodegenerative Disease Research and Clinical Practice”
2024 RESEARCH CALL ON “MECHANISMS AND MEASUREMENT OF DISEASE PROGRESSION IN THE EARLY PHASE OF NEURODEGENERATIVE DISEASES”
- Country-Specific Details
- MECHANISMS AND MEASUREMENT OF DISEASE PROGRESSION IN THE EARLY PHASE OF NEURODEGENERATIVE DISEASES PROJECTS
2025 RESEARCH CALL ON HEALTH AND SOCIAL CARE RESEARCH WITH A FOCUS ON THE MODERATE AND LATE STAGES OF NEURODEGENERATIVE DISEASES
- Country-Specific Details
5 – Presentation Slides
6 – Presentation Slides
a – Philippe Amouyel, JPND Chair
A JPND-ről
A JPND-ről
À propos du JPND
À propos du JPND
Abbreviations list
About JPND
About the Portal
Accessibility
Acerca del JPND
Acerca del JPND
ActifCare
ADAGE: Pietro CORTELLI
ADAGE: Pietro CORTELLI
Add Or Update A Cohort
Aké sú ciele JPND?
Alignment Actions
Alignment of National Activities
Alignment of National Strategies
ALS-CarE
Animal and Cell Models
Annual Calls for Proposals
Antibody Therapy Creates New Opportunities For Treating Brain Diseases
APGeM
Assisted Living Technologies
b – Thomas Gasser, SAB Chair
Basic Research
BIOMARKAPD
BIOMARKAPD
BIOMARKAPD: Bengt WINBLAD
Biomarkers Call 2011
- Biomarker Projects
- National Contact Representatives
Brain Imaging Working Groups 2016
Building a Consortium
Building a consortium
C.elegans
Call for Working Groups
Call Statistics
Call Text
Care sunt obiectivele JPND?
Ce?
Cele JPND
Çfarë?
Che cos’è JPND
Che cos’è JPND
Cilat janë objektivat e JPND-së?
CLASP
Clinical Research
Closed Calls
Co?
Čo?
Cohort CSV
Cohort entry form
Cohort entry form OLD
Comparison View
Contact
Cookie Policy
Cosa?
COURAGE-PD
Cože?
Creating a major impact on neurodegenerative research funding in Europe
Cross-Disease Analysis 2013
- Country-specific details 2013
- Cross-Disease Analysis Projects
CSA BrainHealth
CSFQUIC
Data Collected
Data Hubs
Database CSV
Database Help
DB Sitemap
Defeating Dementia
Delivery of the Research Strategy
DEMTEST
Despre JPND
Despre JPND
Dissemination + Communication
EADB: Jean-Charles LAMBERT
Enabling collaborative research in Alzheimer’s and Parkinson’s diseases
European Research Infrastructure Consortium (ERIC)
Evaluation and Decision
Evaluation and Decision
Executive Board
Expert workshops
Extranet
FAQ
FAQ
FAQ
Feedback Survey
Feedback Survey
Final Workshop
General Framework
General Framework
Global Cohort Portal
Global Cohort Portal Blog
Goals
Governance
Health and Social Care 2018
- Country-specific details
Health and social care projects
Health and Social Care Research with a Focus on the Moderate and Late Stages of Neurodegenerative Diseases Projects
Healthcare Evaluation 2012
- Healthcare Evaluation Projects
Healthcare Research
Home
Home
How to use the Portal
Hva er målene til JPND?
Hva?
Hvad?
Hvilke målsætninger har JPND?
Implementation Plan, 2012-2014
INCURE
Industry Meeting
Industry Partnership
Informacje o JPND
Informacje o JPND
Interview with SAB Chair Professor Thomas Gasser
Jaké jsou cíle programu JPND?
Join Us
Joint Programming
JPco-fuND
JPco-fuND 2
JPco-fuND Intermediate Symposium
JPND – predstavitev
JPND – predstavitev
JPND Hakkında
JPND Hakkında
JPND La
JPND Launches Updated Research and Innovation Strategy
JPND Logo
JPND publications with Open Access Government
JPND SYMPOSIUM 2019
JPND SYMPOSIUM 2022
JPND SYMPOSIUM 2024
JPND-supported funded projects 2022 Pre-Call Announcement: Understanding the Mechanisms of Non-Pharmacological Interventions
JPND’nin Hedefleri nelerdir?
JPND/JPcofuND Symposiums
JUMPAHEAD
Kaj?
Katere cilje smo si postavili pri JPND?
Koji su ciljevi JPND inicijative?
Launch of the 2012 Research Strategy
Link to Mapping Exercise
Linked Activities
List View
Load More
Load More List
Longitudinal Cohorts
Luca Kleineidam – EADB
Major Activities
Management Board
Matrix View
MEETINGDEM
MEETINGDEM
Melyek a JPND céljai?
Mi az?
MIND-AD: Miia KIVIPELTO
Mitä?
Mitkä ovat JPND:n tavoitteet?
Monitoring and Evaluation
Mutations in TMEM230 are rare in autosomal dominant Parkinson’s disease
Ne?
NEEDS in ALS
Network of Centres of Excellence
Neurodegenerative disease research without boundaries
NeuTargets: Chiara Zurzolo
New discovery is a step towards developing Huntington’s disease treatments before symptoms appear
News & Media
Niamh M. C. Connolly – CeBioND
O iniciatíve JPND
O iniciatíve JPND
O programu JPND
O programu JPND
O programu JPND
O programu JPND
O quê?
Om JPND
Om JPND
Om JPND
Om JPND
Om JPND
Om JPND
One-to-One consultations
Online Consultation
Operating Plan
Optimisation of biomarkers
Other Portals
Our Strategy
Over JPND.
Over JPND.
Palliative Care
Participating Centres of Excellence
Pathways 2017
- Country-specific details
- Pathways projects
Patient + Public Involvement
Patient and Carer Meeting
Patient and Public Involvement at the heart of brain research
PERADES
Personalised Medicine Projects
Photo Gallery
PPI
PPI Stakeholder Advisory Board
Pre-call announcement
PRE-CALL ANNOUNCEMENT FOR JPND 2023 CALL: LARGE SCALE ANALYSIS OF OMICS DATA FOR DRUG-TARGET FINDING IN NEURODEGENERATIVE DISEASES
PRE-CALL ANNOUNCEMENT FOR JPND 2023 WORKING GROUPS CALL: USE OF DIGITAL TECHNOLOGIES IN NEURODEGENERATIVE DISEASE RESEARCH AND CLINICAL PRACTICE
PRE-CALL ANNOUNCEMENT FOR JPND 2025 CALL: HEALTH AND SOCIAL CARE RESEARCH WITH A FOCUS ON THE MODERATE AND LATE STAGES OF NEURODEGENERATIVE DISEASES
Precision Medicine Workshop
Preclinical and Clinical Neuroscience Research through Data Reuse
Presentations
Preventive Strategies 2013
- National-level details
- Preventive Strategy Pilot Projects
Privacy
Proposal Submission Tool
Proposal Template
Public Health Workshop
Qu’est-ce que c’est ?
Quais são os objetivos da JPND?
Quali sono gli obiettivi della JPND?
Quels sont les objectifs du JPND ?
Questionnaire on Non-Human Primates
Relevant Links
Research Mapping
Results of First CoEN Call
Results of Second CoEN Call
Results of the 2021 JPND Working Groups Call: The Impact of Covid-19 on Neurodegenerative Disease Research
RESULTS OF THE 2022 JPND EXPERT WORKING GROUPS CALL FOR “CONCEPTS FOR HEALTH AND SOCIAL CARE RESEARCH FOR NEURODEGENERATIVE DISEASES”
Results of the 2023 Working Groups Call: Use of Digital Technologies in Neurodegenerative Disease Research and Clinical Practice
Results of the Fourth CoEN Call
Results of Third CoEN Call
RHAPSODY
RiMod-FTD
RiMod-FTD: Peter HEUTINK
Risk Factors 2012
- Risk Factor Projects
Risk Factors, Models and Cohorts 2015
Rreth JPND-së
Rreth JPND-së
RSS feed & E-mail alert
RSS feed & E-mail alert
RSS Help
SAB Interviews
Sample Page with Accordian
Scientific Advisory Board
Search our Database
Search our Database OLD
Sitemap
Sobre a JPND
Sobre a JPND
SOPHIA
Specific regulations
Stakeholder Consultation
Stakeholder Consultations
Stakeholder Database
Stakeholder Database Entry
Što?
STRENGTH
Submit Form Via Email
Supported Projects
Supported Projects Test
Test Page
The largest global collaborative initiative for neurodegenerative disease research
Third Country Participation
Tietoa JPND:stä
Tietoa JPND:stä
Towards a stronger brain health partnership
Twitter
Über JPND
Über JPND
USA conference
Vad?
Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease
Vilka är JPND:s mål?
Vincent Baudouin – PrPCPDK1
Was sind die Ziele von JPND?
Wat zijn de doelstellingen van JPND?
Wat?
What?
What? – Test
What? – Test Fra
What? – Test Ger
Why?
Wie?
Workshops & Questionnaire
Writing a Proposal
Writing a Proposal
YouTube Videos
Ποιοι είναι οι στόχοι του προγράμματος JPND
Σχετικά με το JPND
Σχετικά με το JPND
Τι;
За JPND
За JPND
Какви са целите на JPND?
Какво?
אודות JPND
אודות JPND
מה?
מהן מטרות JPND?
حول JPND
حول JPND
ما هي أهداف JPND؟
ماذا؟

This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.

Home
About JPND

Search of mechanisms responsible for adverse effects of amyloid beta on muscarinic receptor transmission

HomesurveySearch of mechanisms responsible for adverse effects of amyloid beta on muscarinic receptor transmission

Investments < €500k
Czech Republic

2016

Previous Post Tau in Central Nervous System: neurotoxic and autoimmune component

Next Post Intrathecal and intramuscular application of mesenchymal stem cells and their secretome in the treatment of amyotrophic lateral sclerosis

ABOUT JPND

The EU Joint Programme – Neurodegenerative Disease Research (JPND) is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases, in particular, Alzheimer’s.

BROWSE CATEGORIES

Call Results
Symposiums
JPND News
JPND Surveys
Publications
Press Releases

This initiative received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreements No. 643417, No. 681043 and No. 825664.

Post

Post

Filter